4-phenylenediamine has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barboni, P; Carelli, V; La Morgia, C; Lodi, R; Malucelli, E; Manners, D; Randhawa, RS; Rizzo, G; Ross-Cisneros, FN; Sadun, AA; Testa, C; Tonon, C; Tozer, KR; Valentino, ML | 1 |
Foote, T; Gu, XZ; Sadun, AA; Tsai, JC; Wall, M; Wurdeman, A | 1 |
2 other study(ies) available for 4-phenylenediamine and Atrophy
Article | Year |
---|---|
Secondary post-geniculate involvement in Leber's hereditary optic neuropathy.
Topics: Adult; Aged; Atrophy; Brain Mapping; Case-Control Studies; Diffusion; Diffusion Magnetic Resonance Imaging; DNA, Mitochondrial; Female; Heterozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Nerve Fibers; Neurons; Optic Atrophy, Hereditary, Leber; Optic Nerve; Phenylenediamines; Vision, Ocular | 2012 |
Pattern of axonal loss in longstanding papilledema due to idiopathic intracranial hypertension.
Topics: Adult; Atrophy; Axons; Cell Count; Cell Death; Fundus Oculi; Humans; Image Processing, Computer-Assisted; Lipids; Male; Myelin Sheath; Nerve Degeneration; Nerve Fibers; Obesity; Optic Nerve; Papilledema; Phenylenediamines; Pseudotumor Cerebri; Staining and Labeling | 1995 |